Merck Foundation marks World Cancer Day by providing 194 Oncology Scholarship to Doctors from 32 African Countries ...

We recently published a list of Jim Cramer Recently Talked About These 9 Stocks. In this article, we are going to take a look ...

Mark T. Esser, a pharmaceutical researcher and executive, brings scientific expertise and leadership experience to his new ...

Top NHS doctor, CEO out. Across the pond, NHS England is also seeing big changes with Sir Stephen Powis announcing his plans ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...

Listen to this article Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and ...

The problem for investors is that Trump in his Oval Office comments referred to pharmaceutical tariffs of “50% or 100% or 200 ...

A potential U.S. launch of this Chinese biotech's new lung cancer drug - which bested Merck's blockbuster Keytruda - is a key ...

The Oakmark Fund’s Investor Share Class returned 1.14% versus -4.27% for the S&P 500 Index for the quarter. Click here to ...

Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The ...

Learn more about whether Legend Biotech Corporation or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...